Trxade Group (NASDAQ: MEDS) was featured in a recent
equity research report published by Dougherty & Company LLC. The report
reads, “We are initiating coverage of Trxade with a Buy rating and Price Target
of $12. MEDS’ primary offering is a web-based platform connecting large
suppliers of branded and generic drugs with retail and independent pharmacies.
The platform offers full price transparency, comparing the prices and
availability across a variety of suppliers. Its latest offering is a
direct-to-consumer application equipped with telemedicine visits which includes
home delivery of medications. MEDS nearly doubled revenue in 2019 and we model
the company increasing sales at close to a 40% clip in 2020, while profitable
for several quarters. We view the stock as a compelling, under-the-radar idea
for small-cap growth investors seeking exposure to digital health and
telemedicine. Our $12 Price Target is based on a 6x multiple on our 2021
forecast, a slightly lower multiple than comps which we justify with a small
cap discount, but considering also MEDS’ superior growth rate.”
To request access to the full report, visit http://ibn.fm/LQ1QX
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASQAQ:
MEDS) is an integrated drug procurement, delivery and healthcare platform that
enables price transparency and increased profit margins to buyers and sellers
of pharmaceuticals, makes healthcare services affordable and accessible across
all 50 states, and steps in to meet today’s immediate demands. Founded in 2010,
Trxade Group is comprised of four synergistic operating platforms; the Trxade
B2B trading platform with 12,100 registered pharmacies, a licensed virtual
Wholesaler, affordable healthcare via its Bonum Health app or web-based
telehealth services, and same day or mail order pharmacy delivery capabilities
via its DelivMeds app featuring its extensive nationwide distribution network.
For additional information, please visit www.Trxade.com.
NOTE TO INVESTORS: The latest news and updates
relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment